Tag:

Vaccine Development

COVID-19: School District In Region Announces Delayed Starting Time COVID-19: School District In Region Announces Delayed Starting Time
Covid-19: School District In Region Announces Delayed Starting Time A school district in Fairfield County announced a change in the starting time for the first day of classes of the new calendar year amid a climb in cases as the highly contagious COVID-19 Omicron strain becomes more prevalent. Darien Public Schools Superintendent Alan Addley announced a two-hour delayed opening schedule on Monday, Jan. 3 to provide teachers with the opportunity to prepare remote and in-person learning for their students "given the expected but undetermined number of students to be quarantined." On Friday, Dec. 31, Westport Schools Superintendent Thomas Scarice said the…
COVID-19: 'Omicron's A Different Animal,' Says Expert, Sounding Alarm Over In-Person Learning COVID-19: 'Omicron's A Different Animal,' Says Expert, Sounding Alarm Over In-Person Learning
Covid-19: 'Omicron's A Different Animal,' Says Expert, Sounding Alarm Over In-Person Learning A pediatrician who is an expert on disease and vaccine development is sounding the alarm about the ability of schools to resume in-person learning during the height of the new wave of the COVID-19 pandemic sparked by a surge of cases from the highly contagious Omicron variant. Connecticut native Dr. Peter Hotez is the dean of the National School of Tropical Medicine at the Baylor College of Medicine and co-director of the Texas Children's Hospital Center for Vaccine Development. "Here's the problem," Hotez said in an interview on MSNBC Wednesday morning, Dec. 29. "We're kind of going off ol…
COVID-19: Booster Shot Significantly Raises Antibody Levels Against Omicron, Moderna Says COVID-19: Booster Shot Significantly Raises Antibody Levels Against Omicron, Moderna Says
Covid-19: Booster Shot Significantly Raises Antibody Levels Against Omicron, Moderna Says A Moderna COVID-19 vaccine booster shot significantly raises the level of antibodies against the new Omicron variant, the company announced on Monday morning, Dec. 20. The currently authorized 50-microgram booster neutralized antibody levels against Omicron approximately 37-fold compared to pre-boost levels and a 100-micrograms dose increased neutralizing antibody levels approximately 83-fold compared to pre-boost levels, the Cambridge, Massachusetts-based company said in a statement. The results are based on laboratory testing. “The dramatic increase in COVID-19 cases from the O…